Eli Lilly Scores Win Over Teva In Alimta Patent Fight
An Indiana federal judge on Tuesday ruled that Teva Parenteral Medicines Inc.'s proposed labeling for a generic version of the cancer drug Alimta would cause physicians to infringe Eli Lilly &...To view the full article, register now.
Already a subscriber? Click here to view full article